Kari Hemminki is a top-class researcher in the field of cancer epidemiology and cancer genomics, he is a professor emeritus of the German Cancer Research Center (Deutsches Krebsforschungszentrum – DKFZ) in Heidelberg, where he led the Division of Cancer Epidemiology from 2003 to June 2019. Prof. Hemminki comes from Finland where he acquired the degrees of MD, PhD and Assistant professor at the University of Helsinki. He then continued his career in molecular biology during his postdoctoral fellowship at the Johns Hopkins University in Baltimore, MD, USA. He has authored over 1250 papers with approx. 29 000 citations and his H-index is 79.

Since his team at DKFZ comprised up to 30 people, for whom he managed to acquire more than 50% of external, i.e. grant funding, we are confident that prof. Hemminki will bring a crucial managerial know-how that will help increase the competitiveness of the Biomedical Center, but also of the whole faculty and university.

We are looking forward to prof. Hemminki joining us at the beginning of 2020.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 856620.